Stereotaxis, Inc.
AMEX:STXSMedical - Instruments & Supplies
+$0.05 today
- Market cap
- $94.80M
- Beta
- 1.32
- P/E (TTM)
- -8.3
- EPS (TTM)
- -$0.22
Volume 0.90M
Average 0.39M
STXS Net Income
Bottom-line profit, the starting point for calculating cash from operations.
Stereotaxis, Inc.AMEX: STXS
Net Income · Q1 FY2026 · quarter ended Mar 2026
Net income growth accelerates
Q1 FY2026 net income of $5.86M (cash outflow) rose 0.7% year over year, ahead of the -14.5% change in trailing-twelve-month net income. Sequentially, it rose 6.0% from the prior quarter. Over 3 fiscal years it compounded at +5.8% a year.
Context
- Net income amounted to 66.8% of revenue in FY2025, down 22.5 pp from a year earlier.
- Net income grew in size in 2 of the last 3 fiscal years.
What to watch
Whether net income reaches the consensus estimate from 2 analysts of -$20.62M (-4.7%) for the fiscal year ending Dec 2026, a step up from the -10.0% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$5.86M+6.0% QoQ
- Last fiscal yearDec 2025
- -$21.64M-10.0% YoY
- LTMMar 2026
- -$21.68M-14.5% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +0.7% | +34.0% | +33.4 pp |
| 1 year | -10.0% | -4.7% | +5.3 pp |
| 3-year CAGR | +5.8% | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- (21.64M) USD
- Year-over-year change
- +10.0%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (21.64M) | +10.0% |
| FY2024 | 2024-12-31 | (24.05M) | -16.1% |
| FY2023 | 2023-12-31 | (20.71M) | -13.2% |
| FY2022 | 2022-12-31 | (18.29M) | -70.7% |
| FY2021 | 2021-12-31 | (10.72M) | — |
Net Income vs competitors
How STXS compares with its peers on the latest reported figures
- STXS's LTM Mar 2026 net income of $21.68M is the 2nd largest of the 5 companies compared; the peer median is $17.89M.
- Its year-over-year change of -14.5% is the 4th highest of 5, against a peer median of +4.3%.
- Net income amounts to 69.5% of revenue for STXS, versus a peer median of 46.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $29.07M | +39.8% | +15.8% | 71.6% | |
| LTM Mar 2026 | $21.68M | -14.5% | +5.8% | 69.5% | |
| LTM Mar 2026 | $21.57M | -13.1% | -23.0% | 21.7% | |
| LTM Mar 2026 | $14.21M | +21.8% | -0.1% | 13535.2% | |
| LTM Mar 2026 | $10.03M | -33.1% | +55.7% | 20.7% | |
| Peer median (excluding STXS) | $17.89M | +4.3% | +7.9% | 46.6% | |
Competitors are the stored peer set for STXS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (10.72M) | (18.29M) | (20.71M) | (24.05M) | (21.64M) |
| Depreciation & Amortization | 106K | 429K | 595K | 969K | 1.56M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 9.36M | 10.58M | 10.62M | 10.26M | 9.85M |
| Change in Working Capital | 135K | (1.1M) | 612K | 2.51M | (5.62M) |
| Accounts Receivables | (1.89M) | 316K | 1.27M | 691K | (2.02M) |
| Inventory | (1.14M) | (2.91M) | (550K) | 677K | (1.24M) |
| Accounts Payables | 1.43M | (169K) | 218K | 758K | (880K) |
| Other Working Capital | 1.73M | 1.66M | (324K) | 379K | (1.48M) |
| Other Non-Cash Items | (1.83M) | (25K) | (256K) | 1.81M | 2.17M |
| Operating Cash Flow | (2.95M) | (8.42M) | (9.14M) | (8.5M) | (13.69M) |
| Capital Expenditures | (1.4M) | (2.38M) | (366K) | (34K) | (93K) |
| Acquisitions (Net) | 0 | 0 | 0 | 108K | 0 |
| Purchases of Investments | 0 | (19.72M) | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 20.13M | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (1.4M) | (22.09M) | 19.77M | 74K | (93K) |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 547K | 220K | 81K | 297K | 14.76M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | 547K | 220K | 81K | 297K | 14.76M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (3.8M) | (30.29M) | 10.71M | (8.13M) | 985K |
| Free Cash Flow | (4.34M) | (10.79M) | (9.51M) | (8.53M) | (13.78M) |
Stereotaxis, Inc.
AMEX:STXS
Intrinsic Alpha fair value
Locked
Current Price
$0.95
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.